Skip to main content
Caplight Logo









Magnitude Biosciences

Magnitude Biosciences

Private
SedgefieldHealthcare & Life Scienceshttps://magnitudebiosciences.com/

Last Round

Seed

May 27, 2025

Total Funding Raised

$3.47M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Magnitude Biosciences is a biotechnology company that provides contract research services using a patented in-vivo testing platform with C. elegans and automated imaging technology to accelerate drug discovery and toxicity testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Computer Vision, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

contract research organizationCROC. elegans screeningpreclinical CROlongevity researchneurodegeneration researchhigh-throughput screeningtoxicity testinggerosciencedrug discovery servicesphenotypic screeninghealthspan assaysalternative to animal testingnew approach methodologiesNAMsin vivo toxicologynutraceutical testingmicrobiome researchcomputer vision analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Magnitude Biosciences Comparables

Compare Magnitude Biosciences with similar companies based on industry and business-model similarity.

Magnitude Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ora Biomedical, Inc.
87%
InVivo Biosystems
83%
vivoVerse
83%

Magnitude Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 27, 2025
GrantJun 5, 2023
GrantNov 15, 2022
Convertible DebtAug 21, 2020
SeedDec 2, 2019
Seed
Sep 1, 2019

Key People

Founding team and executive leadership

Fozia Saleem

Chief Executive Officer

Executive Team

Magnitude Biosciences Investors

Notable investors and investment history

Magnitude Biosciences investors
InvestorRounds
Future FundConvertible Debt
British Business BankSeed
Innovate UKGrant, Seed
Saker Capital LLPGrant, Convertible Debt, Seed
Northstar VenturesConvertible Debt, Grant, Seed
Innovate UKSeed
Maven Capital PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors grew 6464% MoM, from 28 to 1.8K.

  • May 27, 2025

    $943K raised in an unknown series round.

Magnitude Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Magnitude Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Magnitude Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSedgefield
Employee Range20
Year Founded2018
Last FundingMay 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?